Infectious Diseases Consultation - CMV Prophylaxis
Date: 2025-09-19

Reason: Post-transplant prophylaxis planning.

History:
CMV serostatus D+/R- (high risk). EBV R+. No allergy history relevant to antivirals.

Assessment:
High-risk CMV mismatch. Early post-op renal function improving (Cr 3.6 mg/dL, eGFR ~35). Leukocytes 6.2k.

Plan:
- Start valganciclovir 450 mg PO daily (renally adjusted); increase to 900 mg daily when eGFR >60.
- Duration: 6 months post-transplant.
- Continue TMP-SMX SS daily for PJP (≥6 months).
- BK virus PCR monthly x 6 months.
- Vaccines: No live vaccines; inactivated influenza ≥1 month post-transplant.
- Monitor CBC weekly initially for leukopenia.
